Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan

Y. M. Chang, W. C. Li, C. T. Huang, C. G. Huang, K. C. Tsao, Y. H. Cheng, S. L. Chiang, S. Y. Yang, C. H. Chen, Y. C. Huang

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We studied the effectiveness of oseltamivir during an outbreak of influenza A among previously vaccinated patients and staff in a long-term care facility. Seven of 14 staff members and 14 of 41 residents developed either influenza-like illness (ILI) or other respiratory symptoms during a 14-day period from late January to 8 February 2004. On 9 February, therapeutic oseltamivir (75 mg twice daily for five days) was administered to one staff member and seven residents who had developed ILI within the previous 48 h (treatment group). Prophylactic oseltamivir (75 mg once daily for seven days) was administered to 12 staff members and 30 residents who were asymptomatic or whose respiratory symptoms did not meet the diagnosis of ILI (prophylaxis group). The remaining four residents and one staff member had had ILI for more than two days (with subsiding symptoms) and did not receive oseltamivir ('no-oseltamivir' group). None of the 42 subjects in the prophylaxis group developed ILI. Presence of influenza A virus was demonstrated in 24 subjects: seven out of eight in the treatment group, 12 of 42 in the prophylaxis group and all five in the no-oseltamivir group. For confirmation of diagnosis, real-time reverse transcription-polymerase chain reaction was more sensitive than antigen detection and virus isolation. In-time therapeutic and prophylactic oseltamivir successfully interrupted an outbreak of influenza A in a long-term care facility.

Original languageEnglish
Pages (from-to)83-87
Number of pages5
JournalJournal of Hospital Infection
Volume68
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Oseltamivir
Long-Term Care
Taiwan
Human Influenza
Disease Outbreaks
Influenza A virus
Therapeutics
Reverse Transcription
Viruses
Antigens
Polymerase Chain Reaction

Keywords

  • Influenza
  • Long-term care facility
  • Oseltamivir
  • Outbreak

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Chang, Y. M., Li, W. C., Huang, C. T., Huang, C. G., Tsao, K. C., Cheng, Y. H., ... Huang, Y. C. (2008). Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan. Journal of Hospital Infection, 68(1), 83-87. https://doi.org/10.1016/j.jhin.2007.08.022

Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan. / Chang, Y. M.; Li, W. C.; Huang, C. T.; Huang, C. G.; Tsao, K. C.; Cheng, Y. H.; Chiang, S. L.; Yang, S. Y.; Chen, C. H.; Huang, Y. C.

In: Journal of Hospital Infection, Vol. 68, No. 1, 01.2008, p. 83-87.

Research output: Contribution to journalArticle

Chang, YM, Li, WC, Huang, CT, Huang, CG, Tsao, KC, Cheng, YH, Chiang, SL, Yang, SY, Chen, CH & Huang, YC 2008, 'Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan', Journal of Hospital Infection, vol. 68, no. 1, pp. 83-87. https://doi.org/10.1016/j.jhin.2007.08.022
Chang, Y. M. ; Li, W. C. ; Huang, C. T. ; Huang, C. G. ; Tsao, K. C. ; Cheng, Y. H. ; Chiang, S. L. ; Yang, S. Y. ; Chen, C. H. ; Huang, Y. C. / Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan. In: Journal of Hospital Infection. 2008 ; Vol. 68, No. 1. pp. 83-87.
@article{0852a53c92a34c4db1f1f6836cf04c2c,
title = "Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan",
abstract = "We studied the effectiveness of oseltamivir during an outbreak of influenza A among previously vaccinated patients and staff in a long-term care facility. Seven of 14 staff members and 14 of 41 residents developed either influenza-like illness (ILI) or other respiratory symptoms during a 14-day period from late January to 8 February 2004. On 9 February, therapeutic oseltamivir (75 mg twice daily for five days) was administered to one staff member and seven residents who had developed ILI within the previous 48 h (treatment group). Prophylactic oseltamivir (75 mg once daily for seven days) was administered to 12 staff members and 30 residents who were asymptomatic or whose respiratory symptoms did not meet the diagnosis of ILI (prophylaxis group). The remaining four residents and one staff member had had ILI for more than two days (with subsiding symptoms) and did not receive oseltamivir ('no-oseltamivir' group). None of the 42 subjects in the prophylaxis group developed ILI. Presence of influenza A virus was demonstrated in 24 subjects: seven out of eight in the treatment group, 12 of 42 in the prophylaxis group and all five in the no-oseltamivir group. For confirmation of diagnosis, real-time reverse transcription-polymerase chain reaction was more sensitive than antigen detection and virus isolation. In-time therapeutic and prophylactic oseltamivir successfully interrupted an outbreak of influenza A in a long-term care facility.",
keywords = "Influenza, Long-term care facility, Oseltamivir, Outbreak",
author = "Chang, {Y. M.} and Li, {W. C.} and Huang, {C. T.} and Huang, {C. G.} and Tsao, {K. C.} and Cheng, {Y. H.} and Chiang, {S. L.} and Yang, {S. Y.} and Chen, {C. H.} and Huang, {Y. C.}",
year = "2008",
month = "1",
doi = "10.1016/j.jhin.2007.08.022",
language = "English",
volume = "68",
pages = "83--87",
journal = "Journal of Hospital Infection",
issn = "0195-6701",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan

AU - Chang, Y. M.

AU - Li, W. C.

AU - Huang, C. T.

AU - Huang, C. G.

AU - Tsao, K. C.

AU - Cheng, Y. H.

AU - Chiang, S. L.

AU - Yang, S. Y.

AU - Chen, C. H.

AU - Huang, Y. C.

PY - 2008/1

Y1 - 2008/1

N2 - We studied the effectiveness of oseltamivir during an outbreak of influenza A among previously vaccinated patients and staff in a long-term care facility. Seven of 14 staff members and 14 of 41 residents developed either influenza-like illness (ILI) or other respiratory symptoms during a 14-day period from late January to 8 February 2004. On 9 February, therapeutic oseltamivir (75 mg twice daily for five days) was administered to one staff member and seven residents who had developed ILI within the previous 48 h (treatment group). Prophylactic oseltamivir (75 mg once daily for seven days) was administered to 12 staff members and 30 residents who were asymptomatic or whose respiratory symptoms did not meet the diagnosis of ILI (prophylaxis group). The remaining four residents and one staff member had had ILI for more than two days (with subsiding symptoms) and did not receive oseltamivir ('no-oseltamivir' group). None of the 42 subjects in the prophylaxis group developed ILI. Presence of influenza A virus was demonstrated in 24 subjects: seven out of eight in the treatment group, 12 of 42 in the prophylaxis group and all five in the no-oseltamivir group. For confirmation of diagnosis, real-time reverse transcription-polymerase chain reaction was more sensitive than antigen detection and virus isolation. In-time therapeutic and prophylactic oseltamivir successfully interrupted an outbreak of influenza A in a long-term care facility.

AB - We studied the effectiveness of oseltamivir during an outbreak of influenza A among previously vaccinated patients and staff in a long-term care facility. Seven of 14 staff members and 14 of 41 residents developed either influenza-like illness (ILI) or other respiratory symptoms during a 14-day period from late January to 8 February 2004. On 9 February, therapeutic oseltamivir (75 mg twice daily for five days) was administered to one staff member and seven residents who had developed ILI within the previous 48 h (treatment group). Prophylactic oseltamivir (75 mg once daily for seven days) was administered to 12 staff members and 30 residents who were asymptomatic or whose respiratory symptoms did not meet the diagnosis of ILI (prophylaxis group). The remaining four residents and one staff member had had ILI for more than two days (with subsiding symptoms) and did not receive oseltamivir ('no-oseltamivir' group). None of the 42 subjects in the prophylaxis group developed ILI. Presence of influenza A virus was demonstrated in 24 subjects: seven out of eight in the treatment group, 12 of 42 in the prophylaxis group and all five in the no-oseltamivir group. For confirmation of diagnosis, real-time reverse transcription-polymerase chain reaction was more sensitive than antigen detection and virus isolation. In-time therapeutic and prophylactic oseltamivir successfully interrupted an outbreak of influenza A in a long-term care facility.

KW - Influenza

KW - Long-term care facility

KW - Oseltamivir

KW - Outbreak

UR - http://www.scopus.com/inward/record.url?scp=37849053395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37849053395&partnerID=8YFLogxK

U2 - 10.1016/j.jhin.2007.08.022

DO - 10.1016/j.jhin.2007.08.022

M3 - Article

C2 - 17945389

AN - SCOPUS:37849053395

VL - 68

SP - 83

EP - 87

JO - Journal of Hospital Infection

JF - Journal of Hospital Infection

SN - 0195-6701

IS - 1

ER -